Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Omnicell Inc 4220 NORTH FREEWAY FORT WORTH TX 76137 USA

www.omnicell.com Employees: 3,670 P: 877-415-9990

Sector:

Medical

Description:

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.

Key Statistics

Overview:

Market Capitalization, $K 1,777,578
Enterprise Value, $K 1,582,698
Shares Outstanding, K 44,877
Annual Sales, $ 1,112 M
Annual Net Income, $ 12,530 K
Last Quarter Sales, $ 310,630 K
Last Quarter Net Income, $ 5,460 K
EBIT, $ 17,140 K
EBITDA, $ 110,680 K
60-Month Beta 0.83
% of Insider Shareholders 2.52%
% of Institutional Shareholders 97.70%
Float, K 43,746
% Float 97.48%
Short Volume Ratio 0.50

Growth:

1-Year Return -13.72%
3-Year Return -16.68%
5-Year Return -65.65%
5-Year Revenue Growth 23.99%
5-Year Earnings Growth -52.51%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.51 on 10/30/25
Next Earnings Date N/A
Earnings Per Share ttm 1.09
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year -11.11%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

OMCL Ratios

Ratio
Price/Earnings ttm 37.14
Price/Earnings forward 40.92
Price/Earnings to Growth 4.76
Return-on-Equity % 4.10%
Return-on-Assets % 2.44%
Profit Margin % 1.13%
Debt/Equity 0.00
Price/Sales 1.63
Price/Cash Flow 12.56
Price/Book 1.41
Book Value/Share 27.20
Interest Coverage -1.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar